Microfluidic Is Estimated To Witness High Growth Owing To Opportunity In Healthcare Applications

Pharmaceuticals
Sachin CMI's picture

Microfluidics involves handling and processing of extremely small fluid volumes, which are generally in the range of microliters or even picoliters. Microfluidics based systems offer significant advantages such as lower reagent consumption, portability, reduced analysis time, and ability to integrate complex fluidic manipulations on a single microchip. Microfluidics has applications in biomedical research, medical diagnostics, drug discovery, and healthcare.

The global Microfluidic Market is estimated to be valued at Us$ 22.3 Bn in 2023 and is expected to exhibit a CAGR Of 4.0% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

Healthcare applications offer lucrative opportunities for growth of the microfluidic market. Continuous population growth and rising incidence of diseases have increased demand for advanced medical diagnostics with faster and reliable results. Microfluidic systems enable easy automation of complex biochemical assays with reduced sample volume requirement. This allows for point-of-care testing and decentralized healthcare delivery. Microfluidic immunoassays and molecular diagnostics have potential to facilitate on-site and real-time detection of infectious diseases and genetic disorders. Further development of microfluidic devices integrated with micro-sensors and portable analyzers could disrupt in-vitro diagnostics. Growing investments in development of microfluidic based diagnostic platforms will positively influence the market over the forecast period.

Porter’s Analysis

Threat of new entrants: Low to moderate as the microfluidic market requires high capital investment and established distribution channels. However, threat is increasing as technology startup are developing novel products.

Bargaining power of buyers: Moderate as microfluidic devices find application in various industries such as healthcare, chemical, oil & gas etc. Hence buyers have choice of products.

Bargaining power of suppliers: Moderate as there are established suppliers of raw materials, components and technology. However, specialty suppliers hold strong position in supplying critical components.

Threat of new substitutes: Low as microfluidic devices provide unique advantages over conventional techniques in terms of miniaturization, automation, portability etc.

Competitive rivalry: High due to presence of numerous global and local players operating in segments such as microfluidic chips, microfluidic sensors etc. Focus on R&D and new product launches.

SWOT Analysis


Strength: Microfluidic devices offer miniaturization, portability and automation. Growing adoption in healthcare and diagnostics.

Weakness: High initial investment and complexity in fabrication. Limitations in scaling production. Requirement of specialty equipment and skilled workforce.

Opportunity: Untapped growth potential in developing regions. Widespread application across industries with development of specialized products.

Threats: Stiff competition. Stringent regulations pertaining to healthcare devices. Vulnerability to pricing pressures.

Key Takeaways


The Global Microfluidic Market Demand is expected to witness high growth with a CAGR of 4.0% during the forecast period of 2023 to 2030. The market size for 2024 is estimated to be US$ 22.3 Bn.

Regional analysis:

North America dominates the global microfluidic market with over 40% share due to strong presence of key players, robust funding and adoption across healthcare sector. Asia Pacific shows fastest growth supported by low-cost manufacturing, rapidly increasing R&D investments and rising healthcare expenditure in countries such as China and India.

Key players analysis:

Key players operating in the microfluidic market are Nike, Adidas AG, Borosil, Milton, H2O International SA., shanghai Atlantis Industry Co. Ltd, SIGG Switzerland Bottles AG, Decathlon S.A., Puma SE, and Camlin Kokuyo. These companies are focusing on portfolio expansion and strategic collaborations for technology advancement and geographic expansion.

 

Get more insights on this topic :

http://www.pressreleasebulletin.com/the-global-microfluidic-market-is-estimated-to-propelled-by-increasing-demand-for-point-of-care-diagnostics-and-drug-discovery-applications/

Get more insights on this topic : 

https://careersplay.com/how-biochips-are-reshaping-the-landscape-of-medical-advancement-in-healthcare-industry